BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30593799)

  • 21. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
    Ge D; Fellay J; Thompson AJ; Simon JS; Shianna KV; Urban TJ; Heinzen EL; Qiu P; Bertelsen AH; Muir AJ; Sulkowski M; McHutchison JG; Goldstein DB
    Nature; 2009 Sep; 461(7262):399-401. PubMed ID: 19684573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of rs2111485 and rs1990760 Polymorphisms of Interferon Induced with Helicase C Domain 1 Gene with Hepatitis C Virus Clearance in Chinese Han Population.
    Jiang W; Zhuo L; Wu X; Shen J; Ye X; Wang Y; Xia X; Chen H; Yu R; Yang S; Huang P
    Viral Immunol; 2019 Oct; 32(8):341-347. PubMed ID: 31539314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon lambda 4 gene polymorphisms as a predicting tool of response to hepatitis C virus genotype 4 patients treated with Sofosbuvir and Ribavirin.
    Sakr AA; Ahmed AE; Abd El-Maksoud MDE; Gamal A; El-Garem H; Ahmed OM
    Infect Genet Evol; 2020 Dec; 86():104606. PubMed ID: 33127459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children.
    Indolfi G; Azzari C; Resti M
    World J Gastroenterol; 2014 Jul; 20(28):9245-52. PubMed ID: 25071317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.
    Sticchi L; Di Biagio A; Rappazzo E; Setti M; De Rosa G; De Hoffer L; Nicolini L; Prinapori R; Bruzzone B
    J Prev Med Hyg; 2013 Jun; 54(2):83-6. PubMed ID: 24396987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent.
    Wojcik GL; Thio CL; Kao WH; Latanich R; Goedert JJ; Mehta SH; Kirk GD; Peters MG; Cox AL; Kim AY; Chung RT; Thomas DL; Duggal P
    Genes Immun; 2014 Apr; 15(4):241-6. PubMed ID: 24622687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.
    van den Berg CH; Grady BP; Schinkel J; van de Laar T; Molenkamp R; van Houdt R; Coutinho RA; van Baarle D; Prins M
    PLoS One; 2011; 6(11):e27555. PubMed ID: 22110669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk.
    Lee MH; Yang HI; Lu SN; Lin YJ; Jen CL; Wong KH; Chan SY; Chen LC; Wang LY; L'Italien G; Yuan Y; Chen CJ
    Sci Rep; 2015 Nov; 5():17030. PubMed ID: 26602024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
    Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
    BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
    Suppiah V; Gaudieri S; Armstrong NJ; O'Connor KS; Berg T; Weltman M; Abate ML; Spengler U; Bassendine M; Dore GJ; Irving WL; Powell E; Hellard M; Riordan S; Matthews G; Sheridan D; Nattermann J; Smedile A; Müller T; Hammond E; Dunn D; Negro F; Bochud PY; Mallal S; Ahlenstiel G; Stewart GJ; George J; Booth DR;
    PLoS Med; 2011 Sep; 8(9):e1001092. PubMed ID: 21931540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.
    Kurbanov F; Abdel-Hamid M; Latanich R; Astemborski J; Mohamed M; Mikhail NM; El-Daly M; El-Kafrawy S; Thomas DL; Thio CL
    J Infect Dis; 2011 Nov; 204(9):1391-4. PubMed ID: 21933876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium.
    Ng MCY; Graff M; Lu Y; Justice AE; Mudgal P; Liu CT; Young K; Yanek LR; Feitosa MF; Wojczynski MK; Rand K; Brody JA; Cade BE; Dimitrov L; Duan Q; Guo X; Lange LA; Nalls MA; Okut H; Tajuddin SM; Tayo BO; Vedantam S; Bradfield JP; Chen G; Chen WM; Chesi A; Irvin MR; Padhukasahasram B; Smith JA; Zheng W; Allison MA; Ambrosone CB; Bandera EV; Bartz TM; Berndt SI; Bernstein L; Blot WJ; Bottinger EP; Carpten J; Chanock SJ; Chen YI; Conti DV; Cooper RS; Fornage M; Freedman BI; Garcia M; Goodman PJ; Hsu YH; Hu J; Huff CD; Ingles SA; John EM; Kittles R; Klein E; Li J; McKnight B; Nayak U; Nemesure B; Ogunniyi A; Olshan A; Press MF; Rohde R; Rybicki BA; Salako B; Sanderson M; Shao Y; Siscovick DS; Stanford JL; Stevens VL; Stram A; Strom SS; Vaidya D; Witte JS; Yao J; Zhu X; Ziegler RG; Zonderman AB; Adeyemo A; Ambs S; Cushman M; Faul JD; Hakonarson H; Levin AM; Nathanson KL; Ware EB; Weir DR; Zhao W; Zhi D; ; Arnett DK; Grant SFA; Kardia SLR; Oloapde OI; Rao DC; Rotimi CN; Sale MM; Williams LK; Zemel BS; Becker DM; Borecki IB; Evans MK; Harris TB; Hirschhorn JN; Li Y; Patel SR; Psaty BM; Rotter JI; Wilson JG; Bowden DW; Cupples LA; Haiman CA; Loos RJF; North KE
    PLoS Genet; 2017 Apr; 13(4):e1006719. PubMed ID: 28430825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
    Sarkar M; Bacchetti P; Tien P; Mileti E; French AL; Edlin BR; Keller M; Seaberg E; Nowicki MJ; Young M; Peters MG
    Dig Dis Sci; 2013 May; 58(5):1341-8. PubMed ID: 23179159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
    Ansari MA; Aranday-Cortes E; Ip CL; da Silva Filipe A; Lau SH; Bamford C; Bonsall D; Trebes A; Piazza P; Sreenu V; Cowton VM; ; Hudson E; Bowden R; Patel AH; Foster GR; Irving WL; Agarwal K; Thomson EC; Simmonds P; Klenerman P; Holmes C; Barnes E; Spencer CC; McLauchlan J; Pedergnana V
    Elife; 2019 Sep; 8():. PubMed ID: 31478835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.
    Chinnaswamy S
    J Interferon Cytokine Res; 2014 Jul; 34(7):479-97. PubMed ID: 24555572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
    O'Connor KS; George J; Booth D; Ahlenstiel G
    World J Gastroenterol; 2014 Dec; 20(47):17830-8. PubMed ID: 25548481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
    Wu R; Chi X; Wang X; Sun H; Lv J; Gao X; Yu G; Kong F; Xu H; Hua R; Jiang J; Sun B; Zhong J; Pan Y; Niu J
    Infect Genet Evol; 2016 Apr; 39():132-140. PubMed ID: 26820907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J;
    J Clin Virol; 2014 Nov; 61(3):430-4. PubMed ID: 25256151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.